Diploma, B.Pharma, Bsc and Msc applicants can apply. Experience in IPQA, QMS , LMS. Candidate having experience to handle BFS/FFS machine and autoclave operations with troubleshooting. Candidate having experience with rommelag/weiler machine preventive maintenance.
Must have experience in handling HPLC, UPLC Empower-3 software, GC, UV Visible spectrophotometer balances, Potentiometer, and stability chambers. This role involves method development, method validation, method transfer and R&D stability studies by using laboratory instruments like Ultra performance liquid chromatography, High Performance Liquid Chromatography, Gas Chromatography, Ultraviolet spectrophotometer, Polarimeter, etc.
MSc Organic Chemistry / B.Pharm; Development of catalytic ring expansive carbonylation of epoxides and aziridines. Development of catalytic ring expansive carbonylation of epoxides and aziridines
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.
CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) is a premier multidisciplinary research institute of Council of Scientific and Industrial Research (CSIR), India with its major focus on exploiting the potential of medicinal and aromatic plants (MAPs) by cultivation, bioprospection, chemical characterization, extraction, and formulation of bioactive phytomolecules.
Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.